Cytokinetics pharmaceuticals logo
WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential... WebOct 27, 2024 · Cytokinetics hopes to launch omecamtiv mecarbil and aficamten, along with a third drug dubbed reldesemtiv, over the next three years. Reldesemtiv is in testing for amyotrophic lateral sclerosis,...
Cytokinetics pharmaceuticals logo
Did you know?
WebFeb 17, 2024 · Cytokinetics has an analyst consensus of Strong Buy, with a price target consensus of $62.54, representing a 47.2% upside. In a report issued on February 2, … WebDec 13, 2024 · SOUTH SAN FRANCISCO, Calif., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food & Drug Administration (FDA) Cardiovascular and Renal...
WebApr 10, 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 22 nd Annual Needham Virtual Healthcare Conference on Monday, April 17, 2024 at 10:00 … WebCytokine definition, a type of small protein, as interferon, secreted by certain cells, especially immune cells, that helps regulate the body’s immune response to inflammation and …
Webcytokines: Physiology A generic term for any group of proteins that function in coordinated sequences, forming positive feedback loops for expanding the response to a low … WebCytokinetics. Pharmaceuticals · California, United States · 253 Employees . Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining.
WebSep 7, 2024 · The conference call will be simultaneously webcast and will be accessible in the Investors & Media section of Cytokinetics’ website at www.cytokinetics.com. The live audio of the conference call ...
WebDec 13, 2024 · Dec. 13, 2024 at 6:48 p.m. ET. By Josh Beckerman. Cytokinetics Inc. shares declined in late trading after a company drug received an unfavorable vote from a U.S. Food & Drug Administration ... sim only nzWebNov 30, 2024 · CYTOKINETICS® and the CYTOKINETICS and C-shaped logo are registered trademarks of Cytokinetics in the U.S. and certain other countries. Contacts: … sim only number transferWebMar 31, 2024 · Cytokinetics' heart disease drug, aficamten, is a "crown jewel in terms of the pipeline", said Oppenheimer analyst Justin Kim, who expects it could bring more than $1 billion in peak sales from U ... sim only nummerbehoudWebDec 13, 2024 · Dec 13 (Reuters) - The U.S. Food and Drug Administration's panel of outside experts did not lend its support to Cytokinetics Inc's (CYTK.O) heart drug, citing insufficient data on safety and ... sim only no data dealssim only nummer behoudenWebApr 10, 2024 · Vertex Pharmaceuticals (Canada) Inc. logo (CNW Group/Vertex Pharmaceuticals (Canada) Inc.) "With this approval, ... Cytokinetics (CYTK) declines 20% in the year so far as it suffers a regulatory ... sim only no contract singtelWebApr 10, 2024 · CYTOKINETICS® and the CYTOKINETICS and C-shaped logo are registered trademarks of Cytokinetics in the U.S. and certain other countries. Contact: Cytokinetics Diane Weiser Senior Vice President, Corporate Communications, Investor Relations (415) 290-7757 You just read: sim only no monthly charge